Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

被引：0
|
作者：
James Patrick Finnerty
Aravind Ponnuswamy
Prosjenjit Dutta
Ammar Abdelaziz
Hafiz Kamil
机构：
[1] Countess of Chester Hospital NHS Trust,Department of Respiratory Medicine
[2] University of Chester Medical School,undefined
[3] The Walton Centre,undefined
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [32] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [33] Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
    Oda, Keishi
    Matsunaga, Takafumi
    Sennari, Konomi
    Yatera, Kazuhiro
    INTERNAL MEDICINE, 2017, 56 (10) : 1267 - 1268
  • [34] Characteristics of patients with idiopathic pulmonary fibrosis (IPF) initiating nintedanib or pirfenidone treatment compared with untreated patients in the US
    Near, Aimee M.
    Burudpakdee, Chakkarin
    Wallace, Laura
    Hartmann, Nadine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 163 - 164
  • [35] Outcomes of Antifibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Patients with Circulating Autoantibodies
    Smith, A.
    Ding, G.
    Kropski, J.
    Mason, W.
    Lancaster, L. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [36] Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Kou, Mengjia
    Jiao, Yang
    Li, Zhipeng
    Wei, Bin
    Li, Yang
    Cai, Yaodong
    Wei, Wan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (10) : 1445 - 1460
  • [37] The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
    Zang, Chenchen
    Zheng, Yan
    Wang, Yanqing
    Li, Lisha
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2021, 26 (01)
  • [38] The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
    Chenchen Zang
    Yan Zheng
    Yanqing Wang
    Lisha Li
    European Journal of Medical Research, 26
  • [39] Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis
    Dempsey, Timothy M.
    Payne, Stephanie
    Sangaralingham, Lindsey
    Yao, Xiaoxi
    Shah, Nilay D.
    Limper, Andrew H.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (07) : 1121 - 1128
  • [40] MMP28 Is Upregulated in Idiopathic Pulmonary Fibrosis (IPF) Epithelium and Is a Promising Biomarker to Distinguish IPF from Non-IPF Patients
    Maldonado, M.
    Buendia, I.
    Vicens Zygmunt, V.
    Planas, L.
    Molina Molina, M.
    Selman, M.
    Pardo, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
12345